1st Accutane Verdict: $2.62 Million
In the first of 400 suits to be tried over the acne drug Accutane’s propensity to cause inflammatory bowel disease, an Atlantic County, N.J., jury has assessed $2.62 million in damages against Hoffmann-La Roche Inc. and its Swiss parent company. However, the jury of six women and four men did not award punitive damages under New Jersey’s Consumer Fraud Act because they found insufficient evidence the manufacturer intentionally failed to warn the drug can cause IBD.
Read more here.
If you or a loved one have been injured due to a dangerous product, please call Keating, O’Gara, Nedved & Peter at 888/234-0621 or fill out the contact form on this site. Your first consultation is free and we handle cases on a contingency fee basis.


Leave a Reply